“…Indeed, infection of classical immunocompetent mouse models leads to transient colonization, thus impeding their use as a valuable animal models to study chronic disease and the in vivo therapeutic efficacy of drugs (Bernut et al, 2014b). However, in the past few years the development of multiple cellular, non-mammalian and mammalian models have helped to study the chronology and the pathology of Mabs infection (Byrd and Lyons, 1999; Howard et al, 2006; Ordway et al, 2008; Oh et al, 2013; Bernut et al, 2014a; Bakala N'Goma et al, 2015; Roux et al, 2016). Among these new model systems, a few have been validated for their suitability for in vivo drug efficacy studies against Mabs (Ordway et al, 2008; Lerat et al, 2014; Oh et al, 2014; Bernut et al, 2014b).…”